{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:12:11Z","timestamp":1760911931999,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.cyto.2021.155757","type":"journal-article","created":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T01:28:12Z","timestamp":1636162092000},"page":"155757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["In-vitro cytokine production and nasopharyngeal microbiota composition in the early stage of COVID-19 infection"],"prefix":"10.1016","volume":"149","author":[{"given":"Mehmet","family":"Hursitoglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilgun","family":"Is\u0131ksacan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betul","family":"Erismis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faruk","family":"Karandere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alev","family":"Kural","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.Baki","family":"Kumbasar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadriye","family":"Kart Yasar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2021.155757_b0005","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1089\/jir.2015.0072","article-title":"The role of virus infection in deregulating the cytokine response to secondary bacterial infection","volume":"35","author":"Mehta","year":"2015","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.cyto.2021.155757_b0010","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/oxfordjournals.jbchem.a022636","article-title":"Expression of cytokines in bacterial and viral infections and their biochemical aspects","volume":"127","author":"Imanishi","year":"2000","journal-title":"J. Biochem."},{"key":"10.1016\/j.cyto.2021.155757_b0015","first-page":"e14462","article-title":"Changes of serum IL-10, IL-1\u03b2, IL-6, MCP-1, TNF-\u03b1, IP-10 and IL-4 in COVID-19 patients","author":"Lu","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.cyto.2021.155757_b0020","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors","volume":"9","author":"Han","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.cyto.2021.155757_b0025","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cyto.2021.155757_b0030","doi-asserted-by":"crossref","first-page":"A295","DOI":"10.1016\/j.chest.2020.08.295","article-title":"The association of il-6 value, interleukin inhibitors, and outcomes of patients with covid-19 in new york city","volume":"158","author":"Obata","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.cyto.2021.155757_b0035","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.chest.2020.04.024","article-title":"Use of tocilizumab for COVID-19-induced cytokine release syndrome: A cautionary case report","volume":"158","author":"Radbel","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.cyto.2021.155757_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155389","article-title":"Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients","volume":"138","author":"B\u00fclow Anderberg","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2021.155757_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155323","article-title":"Cytokine profile and disease severity in patients with COVID-19","volume":"137","author":"Ghazavi","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2021.155757_b0050","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1056\/NEJMoa2028836","article-title":"Efficacy of Tocilizumab in Patients Hospitalized with Covid-19","volume":"383","author":"Stone","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2021.155757_b0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1399-3062.2008.00348.x","article-title":"Acute effect of low-flux hemodialysis process on the results of the interferon-gamma-based QuantiFERON-TB Gold In-Tube test in end-stage renal disease patients","volume":"11","author":"Hursitoglu","year":"2009","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.cyto.2021.155757_b0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/096120339600500209","article-title":"In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: Lack of relationship with clinical disease activity","volume":"5","author":"Barcellini","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.cyto.2021.155757_b0065","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s10930-020-09935-8","article-title":"Role of oxidative stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) infection: A review","volume":"39","author":"Suhail","year":"2020","journal-title":"Protein J."},{"key":"10.1016\/j.cyto.2021.155757_b0070","article-title":"Significance of serum total oxidant\/antioxidant status in patients with colorectal cancer","volume":"12","author":"Wu","year":"2017","journal-title":"PLoS One."},{"key":"10.1016\/j.cyto.2021.155757_b0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2021.155757_b0080","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.cell.2016.10.020","article-title":"Linking the human gut microbiome to inflammatory cytokine production capacity","volume":"167","author":"Schirmer","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2021.155757_b0085","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1053\/j.gastro.2020.05.048","article-title":"Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization","volume":"159","author":"Zuo","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2021.155757_b0090","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2020-323020","article-title":"Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19","author":"Yeoh","year":"2021","journal-title":"Gut."},{"key":"10.1016\/j.cyto.2021.155757_b0095","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s10096-018-3305-8","article-title":"The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens","volume":"37","author":"Edouard","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.cyto.2021.155757_b0100","doi-asserted-by":"crossref","first-page":"8922","DOI":"10.1038\/s41598-021-88536-6","article-title":"SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition","volume":"11","author":"Braun","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2021.155757_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.625581","article-title":"Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum?","volume":"11","author":"Nardelli","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.cyto.2021.155757_b0110","unstructured":"Coronavirus disease 2019 (COVID-19): Clinical features - UpToDate, (2020). https:\/\/www.uptodate.com\/contents\/coronavirus-disease-2019-covid-19-clinical-features?search=severity of covid&sectionRank=1&usage_type=default&anchor=H4100426989&source=machineLearning&selectedTitle=2~150&display_rank=2#H4100426989 (accessed September 8, 2020)."},{"key":"10.1016\/j.cyto.2021.155757_b0115","unstructured":"J. Oksanen, F.G. Blanchet, M. Friendly, R. Kindt, P. Legendre, D. Mcglinn, P.R. Minchin, R.B. O\u2019hara, G.L. Simpson, P. Solymos, M. Henry, H. Stevens, E. Szoecs, H.W. Maintainer, Package \u201cvegan\u201d Title Community Ecology Package Version 2.5-7, 2020."},{"key":"10.1016\/j.cyto.2021.155757_b0120","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2015.54","article-title":"The Effects of Bowel Preparation on Microbiota-Related Metrics Differ in Health and in Inflammatory Bowel Disease and for the Mucosal and Luminal Microbiota Compartments","volume":"7","author":"Shobar","year":"2016","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.cyto.2021.155757_b0125","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.3389\/fmicb.2016.01703","article-title":"Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status","volume":"7","author":"Di Paola","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cyto.2021.155757_b0130","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2340\/00015555-2859","article-title":"Significant changes in the skin microbiome in patients with chronic plaque psoriasis after treatment with narrowband ultraviolet B","volume":"98","author":"Assarsson","year":"2018","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.cyto.2021.155757_b0135","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13099-020-00391-4","article-title":"Potential role of intestinal microflora in disease progression among patients with different stages of Hepatitis B","volume":"12","author":"Yang","year":"2020","journal-title":"Gut Pathog."},{"key":"10.1016\/j.cyto.2021.155757_b0140","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/gutjnl-2020-323020","article-title":"Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19","volume":"70","author":"Yeoh","year":"2021","journal-title":"Gut."},{"key":"10.1016\/j.cyto.2021.155757_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.570122","article-title":"Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19","volume":"11","author":"Mrityunjaya","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2021.155757_b0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1620\/tjem.236.97","article-title":"Elevated serum levels of heat shock protein 70 are associated with breast cancer","volume":"236","author":"Gunaldi","year":"2015","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.cyto.2021.155757_b0155","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2021.155757_b0160","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/jir.2019.0011","article-title":"Mechanisms by Which the Gut Microbiota Influences Cytokine Production and Modulates Host Inflammatory Responses","volume":"39","author":"Mendes","year":"2019","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.cyto.2021.155757_b0165","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/jmv.26580","article-title":"IL-10 served as an indicator in severe COVID-19 patients","volume":"93","author":"Huang","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cyto.2021.155757_b0170","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139834","article-title":"Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease","volume":"5","author":"Zhao","year":"2020","journal-title":"JCI Insight."},{"key":"10.1016\/j.cyto.2021.155757_b0175","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cyto.2014.11.027","article-title":"The role of IL-10 in microbiome-associated immune modulation and disease tolerance","volume":"75","author":"Levast","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2021.155757_b0180","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.micinf.2015.10.008","article-title":"Control of Klebsiella pneumoniae pulmonary infection and immunomodulation by oral treatment with the commensal probiotic Bifidobacterium longum 51A","volume":"18","author":"Vieira","year":"2016","journal-title":"Microbes Infect."},{"key":"10.1016\/j.cyto.2021.155757_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2011\/892971","article-title":"Importance of IL-10 modulation by probiotic microorganisms in gastrointestinal inflammatory diseases","author":"de Moreno","year":"2011","journal-title":"ISRN Gastroenterol."},{"key":"10.1016\/j.cyto.2021.155757_b0190","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1046\/j.1365-2222.2000.00948.x","article-title":"Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG","volume":"30","author":"T","year":"2000","journal-title":"Clin. Exp. Allergy."},{"key":"10.1016\/j.cyto.2021.155757_b0195","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2021.155757_b0200","doi-asserted-by":"crossref","unstructured":"S. Fadlallah, M. Shams Eddin, E. Rahal, IL-17A in COVID-19: a meta-analysis, (2020). https:\/\/doi.org\/10.21203\/rs.3.rs-85350\/v1.","DOI":"10.21203\/rs.3.rs-85350\/v1"},{"key":"10.1016\/j.cyto.2021.155757_b0205","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2147\/JIR.S278335","article-title":"Inflammatory cytokine: Il-17a signaling pathway in patients present with covid-19 and current treatment strategy","volume":"13","author":"Shibabaw","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.cyto.2021.155757_b0210","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1160","article-title":"Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection","volume":"9","author":"Lee","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.cyto.2021.155757_b0215","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2213-2600(20)30556-7","article-title":"Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial","volume":"9","author":"Tharaux","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.cyto.2021.155757_b0220","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cyto.2019.04.019","article-title":"Hyperactivation of the NLRP3 inflammasome protects mice against influenza A virus infection via IL-1\u03b2 mediated neutrophil recruitment","volume":"120","author":"Niu","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2021.155757_b0225","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.molcel.2018.07.009","article-title":"An Antiviral Branch of the IL-1 Signaling Pathway Restricts Immune-Evasive Virus Replication","volume":"71","author":"Orzalli","year":"2018","journal-title":"Mol. Cell."},{"key":"10.1016\/j.cyto.2021.155757_b0230","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/imm.12704","article-title":"NLRP3 inflammasome mediates interleukin-1\u03b2 production in immune cells in response to Acinetobacter baumannii and contributes to pulmonary inflammation in mice","volume":"150","author":"Kang","year":"2017","journal-title":"Immunology."},{"key":"10.1016\/j.cyto.2021.155757_b0235","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.immuni.2015.03.004","article-title":"Distinct Commensals Induce Interleukin-1\u03b2 via NLRP3 Inflammasome in Inflammatory Monocytes to Promote Intestinal Inflammation in Response to Injury","volume":"42","author":"Seo","year":"2015","journal-title":"Immunity."},{"key":"10.1016\/j.cyto.2021.155757_b0240","unstructured":"J.C. and C. Zimmer, How the Sinovac Covid-19 Vaccine Works - The New York Times, (n.d.). https:\/\/www.nytimes.com\/interactive\/2020\/health\/sinovac-covid-19-vaccine.html (accessed March 25, 2021)."},{"key":"10.1016\/j.cyto.2021.155757_b0245","unstructured":"J.D. Brown, Effect size and eta squared, n.d."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662100346X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662100346X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:42:16Z","timestamp":1760910136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104346662100346X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":49,"alternative-id":["S104346662100346X"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155757","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-vitro cytokine production and nasopharyngeal microbiota composition in the early stage of COVID-19 infection","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155757"}}